About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 91 record(s)
Req # A-2020-000164
The Prices and the Quantities that Health Canada bought from various suppliers under the " MEDICAL DEVICES FOR USE AGAINST COVID 19 LIST OF PRODUCTS AUTHORISED UNDER THE INTERIM ORDER" The list has 108 entries as on May 5th 2020.Organization: Health Canada
May 2020
Req # A-2020-000271
A copy of "reference 8 2017-07-18 Health protection-report-draft" from the Appendices to the Tunney's Pasture redevelopment plan.Organization: Health Canada
May 2020
Req # A-2020-000272
Request copy of Ref 4 2017-07-06 Jeanne Mance report draft from the Appendices to the Tunney's Pasture redevelopment plan.Organization: Health Canada
May 2020
Req # A-2018-001900
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 18-120103-409.Organization: Health Canada
May 2020
Req # A-2018-001933
Adverse Reaction Report (AER) for LEFLUNOMIDE. Report numbers: E2B_01419624, E2B_01498627, E2B_01498638, E2B_01390788, E2B_01409164, E2B_01475273, E2B_01497714, E2B_01461253, E2B_01490416, E2B_01443866, E2B_01421002, E2B_01462455, E2B_01426118, E2B_01495936, E2B_01496885, E2B_01472971, E2B_01474088, E2B_01435278, E2B_01481412, E2B_01436700.Organization: Health Canada
May 2020
Req # A-2019-000059
Adverse Reaction Report (AER). Report numbers: E2B_02116862, E2B_02140911, E2B_02121353, E2B_02104856, E2B_02104861, E2B_02045745, E2B_02130410, E2B_02118199.Organization: Health Canada
May 2020
Req # A-2019-001187
Adverse Reaction Report (AER) for HYDROXYCHLOROQUINE SULFATE.Organization: Health Canada
May 2020
Req # A-2019-001433
Adverse Reaction Report (AER). Report number: E2B_02579035.Organization: Health Canada
May 2020
Req # A-2019-001703
Adverse Reaction Report (AER). Report number: E2B_02786964.Organization: Health Canada
May 2020
Req # A-2019-001750
Adverse Reaction Report (AER). Report numbers: E2B_02284354, E2B_02382135, E2B_02390568, E2B_02407795, E2B_02161795, E2B_00311007.Organization: Health Canada
May 2020